# A SAD/MAD Study to Evaluate the Safety, Tolerability, PK of MT200605 in Healthy Subjects

> **NCT05948774** · PHASE1 · COMPLETED · sponsor: **Shaanxi Micot Pharmaceutical Technology Co., Ltd.** · enrollment: 61 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MT200605 for Injection
- **DRUG:** MT200605 Placebo

## Key facts

- **NCT ID:** NCT05948774
- **Lead sponsor:** Shaanxi Micot Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-11
- **Primary completion:** 2024-01-22
- **Final completion:** 2024-02-11
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05948774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05948774, "A SAD/MAD Study to Evaluate the Safety, Tolerability, PK of MT200605 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05948774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*